Pages that link to "Q72792518"
Jump to navigation
Jump to search
The following pages link to Correlated increases of tumour necrosis factor-alpha, interleukin-6 and granulocyte monocyte-colony stimulating factor levels in suction blister fluids and sera of psoriatic patients--relationships with disease severity (Q72792518):
Displaying 44 items.
- Serum TNF-alpha in psoriasis after treatment with propylthiouracil, an antithyroid thioureylene (Q24803476) (← links)
- Serum leptin and adiponectin levels in Korean patients with psoriasis. (Q33627496) (← links)
- Biologics in the management of psoriasis (Q34620257) (← links)
- Etanercept in the treatment of plaque psoriasis (Q34620263) (← links)
- Perspectives for TNF-alpha-targeting therapies (Q34731078) (← links)
- Emerging role of anti-tumor necrosis factor therapy in rheumatic diseases (Q34731307) (← links)
- Interleukin 6 and 8 levels in plasma and fibroblast cultures in psoriasis (Q35039946) (← links)
- Serum levels of TNF-α, IL-12/23p40, and IL-17 in plaque psoriasis and their correlation with disease severity (Q35155926) (← links)
- Etanercept: An overview (Q35190102) (← links)
- Early effects of tumour necrosis factor alpha blockade on skin and synovial tissue in patients with active psoriasis and psoriatic arthritis (Q35554321) (← links)
- TNFalpha therapy in psoriatic arthritis and psoriasis (Q35554338) (← links)
- Evidence for local inflammation in complex regional pain syndrome type 1. (Q35609427) (← links)
- Tumor necrosis factor-alpha in psoriasis and psoriatic arthritis: a clinical, genetic, and histopathologic perspective (Q35834811) (← links)
- Cutaneous microdialysis: cytokine evidence for altered innate reactivity in the skin of psoriasis patients? (Q35888376) (← links)
- Prevalence of metabolic syndrome in South Indian patients with psoriasis vulgaris and the relation between disease severity and metabolic syndrome: a hospital-based case-control study (Q36352320) (← links)
- Fatigue and interleukin-6 - a multi-faceted relationship (Q36842411) (← links)
- Psoriasis and Sleep Apnea: A Danish Nationwide Cohort Study (Q36897052) (← links)
- Targeted treatment of psoriasis with adalimumab: a critical appraisal based on a systematic review of the literature (Q37303223) (← links)
- Lymphocytes stimulate expression of 5-lipoxygenase and its activating protein in monocytes in vitro via granulocyte macrophage colony-stimulating factor and interleukin 3. (Q37352653) (← links)
- Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation. (Q37377167) (← links)
- Non-invasive evaluation of skin cytokines secretion: an innovative complementary method for monitoring skin disorders (Q38051927) (← links)
- Cytokines and the skin barrier. (Q38093338) (← links)
- Up-regulation of Id1 in peripheral blood of psoriatic patients (Q38339252) (← links)
- Etanercept, improved dosage schedules and combinations in the treatment of psoriasis: an update (Q39180810) (← links)
- Recent advances in the treatment of psoriasis (Q40915788) (← links)
- Topical isoflavonoids reduce experimental cutaneous inflammation in mice (Q43138001) (← links)
- A TNF-α Promoter Polymorphism Is Associated with Juvenile Onset Psoriasis and Psoriatic Arthritis (Q44109850) (← links)
- EGFR regulates the expression of keratinocyte-derived granulocyte/macrophage colony-stimulating factor in vitro and in vivo (Q44238991) (← links)
- Treatment effect of adalimumab and infliximab in Japanese psoriasis patients: Results in a single community‐based hospital (Q53092137) (← links)
- Interleukin-8 Overexpression Is Present in Pyoderma Gangrenosum Ulcers and Leads to Ulcer Formation in Human Skin Xenografts (Q61609542) (← links)
- Role of increased production of monocytes TNF-alpha, IL-1beta and IL-6 in psoriasis: relation to focal infection, disease activity and responses to treatments (Q73088212) (← links)
- Phenotypic Differences between Human Blood Monocyte Subpopulations in Psoriasis and Atopic Dermatitis (Q73554289) (← links)
- Potential role of the chemokine receptors CXCR3, CCR4, and the integrin alphaEbeta7 in the pathogenesis of psoriasis vulgaris (Q73778362) (← links)
- Increased interleukin-6 of skin and serum in amyotrophic lateral sclerosis (Q74147062) (← links)
- Increased serum levels of interleukin (IL)-5, IL-6 and IL-8 in bullous pemphigoid (Q74155567) (← links)
- Plasma concentrations of IFN‐γ and TNF‐α: in psoriatic patients before and after local treatment with dithranol ointment (Q74467595) (← links)
- [Psoriatic arthritis] (Q79424015) (← links)
- Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial (Q81354813) (← links)
- [Etanercept] (Q81573531) (← links)
- [Clinical experience with etanercept in the treatment of psoriasis] (Q81746300) (← links)
- [Long term treatment of psoriasis with TNF-alpha antagonists. Occurrence of malignant melanoma] (Q83464420) (← links)
- Long‐term study of infliximab in Japanese patients with plaque psoriasis, psoriatic arthritis, pustular psoriasis and psoriatic erythroderma (Q84042001) (← links)
- [A new view of psoriasis] (Q84324579) (← links)
- Pathogenesis of psoriasis in the "omic" era. Part I. Epidemiology, clinical manifestation, immunological and neuroendocrine disturbances (Q96134668) (← links)